Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05439590 · ClinicalTrials.gov registry record · NA
Impact of Cottonseed Oil on Oxidative Stress, Inflammation, and Metabolism
A NA study, sponsored by Montana State University.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT05439590 is a NA study that has completed, run by Montana State University. The registered enrollment target is 47 participants.
The verdict
NCT05439590, a NA study, has completed, sponsored by Montana State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
Recent research evidence suggests that cottonseed oil (CSO) may have both direct and indirect anti-inflammatory and anti-oxidative impacts linked to bioactive components of CSO and favorable alterations in lipid metabolism. These impacts are directly related to non-communicable diseases such as diabetes, cardiovascular diseases, and cancer. Our overarching hypothesis is that the effect of CSO consumption on oxidative stress markers (isoprostanes), inflammatory cytokines, metabolic biomarkers, and bile acid metabolism will be beneficial for reversing disease pathophysiology linked to oxidative stress, inflammation, and bile acids. Our long-term goal is to establish effective and practical therapeutic strategies utilizing dietary incorporation of CSO to prevent or reverse these diseases. The following hypotheses will be tested in the proposed investigation: H1: CSO consumption will lower exercise-induced oxidative stress, and the effect of CSO will be greater than that of OO for lowering of exercise-induced oxidative stress. H2: CSO consumption will lower inflammatory cytokines and metabolic markers linked to the inflammation process in human participants, and the effect of CSO will be greater than that of OO for lowering inflammation. H3: Features of serum bile acids, serum metabolomes, and lipidomes distinguishing CSO and OO treatment correspond to metabolic pathways illuminating the health benefits of CSO treatment. H4: Metabolic and inflammatory impacts of dietary oils will be greater for 60 g/d of CSO compared to 30 g/d.
Interventions
- BEHAVIORAL High dose CSO
- BEHAVIORAL Low dose CSO
- BEHAVIORAL Low dose OO
- BEHAVIORAL High dose OO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2022-08-08 |
| Est. Completion | 2023-11-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05439590
The ClinicalTrials.gov registry entry for NCT05439590 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montana State University, which has 36 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which High dose CSO is the first listed.
NCT05439590 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05439590 about?
NCT05439590 is a clinical study titled "Impact of Cottonseed Oil on Oxidative Stress, Inflammation, and Metabolism". Recent research evidence suggests that cottonseed oil (CSO) may have both direct and indirect anti-inflammatory and anti-oxidative impacts linked to bioactive components of CSO and favorable alterations in lipid metabolism. These impacts are directly related to non-communicable diseases such as diab...
What is the current status of trial NCT05439590?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2022-08-08. Estimated completion is 2023-11-03.
What interventions are being tested in trial NCT05439590?
The interventions under investigation include: High dose CSO (BEHAVIORAL), Low dose CSO (BEHAVIORAL), Low dose OO (BEHAVIORAL), High dose OO (BEHAVIORAL).
Who is sponsoring clinical trial NCT05439590?
This trial is sponsored by Montana State University, which has 36 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.